InVivo Plus Anti-Mouse PD-L1 Antibody(10F.9G2) (MV974029)

Name: InVivo Plus Anti-Mouse PD-L1 Antibody(10F.9G2)
Brand: abinScience
SKU: MV974029
Price: 128 USD
Availability: InStock

Datasheet Compartir producto Copiar información

Precio(USD):

Especificación:

1mg
5mg
25mg
50mg
100mg

Número:

Contáctenos

Vista general
Imágenes
Referencias
Datasheet
SDS

Vista general

Número de catálogo	MV974029
Descripción	InVivo Plus Anti-Mouse CD274/PD-L1/B7-H1 Antibody (10F.9G2) [10F.9G2] (MV974029) is a rat monoclonal antibody detecting Programmed cell death 1 ligand 1 in in vivo PD-L1 blockade, in vitro PD-L1 blockade, IF, IHC-F, FCM, WB. Suitable for Mouse. Highlights ●Multi-Application — Validated across multiple applications. ●Flow Cytometry — Validated for flow cytometry applications.
Reactividad de especies	Mouse
Aplicaciones	in vivo PD-L1 blockade, in vitro PD-L1 blockade, IF, IHC-F, FCM, WB
Especie huésped	Rat
Clonalidad	Monoclonal
Isotipo	IgG2b
ID de clon	10F.9G2
Objetivo	B7 homolog 1, B7-H1, B7H1, CD274, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, PDL1, Programmed cell death 1 ligand 1, Programmed death ligand 1
Nivel de endotoxinas	< 1 EU/mg
Pureza	>95% as determined by SDS-PAGE.
Productos asociados	pH 7.4 Dilution Buffer
Purificación	Protein A/G purified from cell culture supernatant.
Número de acceso	Q9EP73
Forma	Liquid
Buffer de almacenamiento	0.01M PBS pH 7.4. Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.
Estabilidad y almacenamiento	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Fondo	Programmed cell death 1 ligand 1 (CD274/PD-L1) is a ~32 kDa protein. Plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response. Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10). CD274 is the therapeutic target of atezolizumab (Tecentriq) and durvalumab (Imfinzi). 1. Tamura, H. et al. (2001) Blood 97, 1809-16. PMID: 11238124 2. Freeman, GJ. et al. (2000) The Journal of experimental medicine 192, 1027-34. PMID: 11015443 3. Wang, S. et al. (2003) The Journal of experimental medicine 197, 1083-91. PMID: 12719480
Nota	For research use only.
Isotype Control	Rat IgG2b Recombinant Isotype Control Antibody (LTF-2) (RF974107)

Imágenes

Bioactivity

Detects Recombinant Mouse CD274/PD-L1/B7-H1 Protein (Cat No.: MV974011) in indirect ELISA.
SDS-PAGE

SDS-PAGE for InVivo Plus Anti-Mouse CD274/PD-L1/B7-H1 Antibody (10F.9G2).